Panagiotis Theofilis

MD, PhD. Resident Cardiologist @ Hippokration General Hospital of Athens, NKUA Medical School. Researcher in the field of cardiovascular medicine

[Panagiotis Theofilis @PTheofilis]

@F1 Hopefully someone crashes on Max as he tries to force someone else off the track on the first corner. Lando manages a p1/2 finish and we move from there.

[Panayotis K. Vlachakis @vlachpanos]

🔥Excited to share our latest paper in @DovePress! This review explores the crucial role of rilonacept in managing recurrent pericarditis, highlighting its effectiveness in reducing recurrence risk and improving patient outcomes. https://t.co/0tuKx5Zb6j

[Panayotis K. Vlachakis @vlachpanos]

📢Novel Treatments in Refractory Recurrent Pericarditis.
👉 https://t.co/GejmczFJGa
@MDPIOpenAccess @PTheofilis @Dr_C_Koutsianas #Cardiology

[Panayotis K. Vlachakis @vlachpanos]

🔥Just released! Our 📝 in @JCM_MDPI explores the unmet needs and gaps in the use of tMCS for HF-related 🫀shock. Emphasizing a 👵 approach, we 📸 the imp of understanding each device's unique benefits in var clin scenarios. @PTheofilis @ILeontsinis
👉https://t.co/MhQocTZ9fl

[Life MDPI @Life_MDPI]

⭐️#Systematic Review:

Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

🎓by Dr. Theofilis et al., from the General Hospital of Nikaia-Piraeus Agios Panteleimon.

📄Enjoy reading: https://t.co/sE3t8egq2g

[Panayotis K. Vlachakis @vlachpanos]

📍Just 🗞️! PE accounts for ~40% of ACSs and mainly affects younger 💃. It differs from PRs with ↘️ inflammation & seasonal variations. Advances in 🖥️ & AI enhance Dx, while 🆕 Tx like antithrombotic 💊 offer promise. @PTheofilis @MDPIOpenAccess @IJMS_MDPI https://t.co/QFXsSqEz88

[Panayotis K. Vlachakis @vlachpanos]

🔥Excited to share that our latest article, 'The Role of Inflammasomes in Heart Failure,' is now published in @IJMS_MDPI ! #HeartFailure #Inflammasomes @PTheofilis @ikachrimanidis @ILeontsinis @AthanasiosKorda @anast_apost @maridrakopoulou
👉https://t.co/AIGm96DkuR #mdpiijms

[Reviews in Cardiovascular Medicine @RCMjournal]

📢#RCM-Vol. 25 No. 3
Systematic Review

The Efficacy of Coronary Sinus Reducer in Patients with Refractory Angina: A Systematic Review and Meta-Analysis

✅by Theofilis et al.
https://t.co/OOVc5kEktM

#CardioEd #CardioTwitter #2024Review #cardiovascular #MedTwitter #Cardiology

[Panayotis K. Vlachakis @vlachpanos]

📍Just published! Our systematic review/meta-analysis on the efficacy of Coronary Sinus Reducer in patients with refractory angina! @RCMjournal @PTheofilis @ManosMantz @stergios87 @OikonomouVangel @ktsioufis_gr
👉https://t.co/0NKq1Rq8bw

[Panayotis K. Vlachakis @vlachpanos]

📰Explore the intricate 🔗 between gut microbiome and cardiometabolic health in our recently published article titled "Targeting the Gut Microbiome to Treat Cardiometabolic Disease." 📚🔬 @PTheofilis @OikonomouVangel @ktsioufis_gr #CardioTwitter https://t.co/E1aZffswlV

[Panayotis K. Vlachakis @vlachpanos]

🗞️ Just Published: Delving into the nuances of ACS, this review spotlights the underexplored realm of sex-based differences. 🚺🚹 Explore the unique facets of ACS in 💃—epidemiology, presentation, and more. Bridging knowledge gaps for better care! https://t.co/cQ3mKph6pQ

[Shockwave Medical @ShockwaveIVL]

To our international customers: Congratulations to Dr. @PTheofilis et al on your meta-analysis presentation at #ESCCongress showing that the Coronary Sinus #Reducer improves symptoms for patients with refractory angina.

ISI https://t.co/sZ0NdzXNcV @escardio #CardioTwitter

[Shockwave Medical @ShockwaveIVL]

To our international customers: Excellent poster session during #ESCCongress featuring the Coronary Sinus #Reducer. Thank you, Drs Gnan @PTheofilis @KevinCCheng & research partners for furthering our knowledge to help patients with refractory angina.

ISI https://t.co/sZ0NdzXNcV

[Edgardo Alania @Ed_Alania]

🟡 Lipoprotein(a) & calcific aortic valve disease initiation and progression @ESC_Journals #CardioEd #Cardiology #CardioTwitter

[Biomedicines MDPI @Biomed_MDPI]

👏 Happy to share our latest Cover Story for Issue 9 (Volume 10). Make sure to check it and sign up for our e-mail alerts to receive table of contents of newly released issues.
Enjoy reading it! 👇
https://t.co/ZoeFqdXAY4

[CVR Tomasz Guzik @CVR_TomaszGuzik]

EDITOR'S CHOICE: What are the #risk factors profile of young & older patients with #myocardial #infarction and why are they different?

Discover more in this must-read review 👉https://t.co/IRtBifsiU5

@ESC_Journals @escardio #MI #CVprev #genetics #CardiovascularResearch

[Panagiotis Theofilis @PTheofilis]

Check out our recently published review article on the non-invasive assessment of vulnerable coronary atherosclerotic plaques. https://t.co/IDHfDixMX3

[Biomedicines MDPI @Biomed_MDPI]

👀𝑹𝒆𝒗𝒊𝒆𝒘 𝒐𝒇 𝒕𝒉𝒆 𝒅𝒂𝒚📖
Inflammatory Mechanisms Contributing to Endothelial Dysfunction https://t.co/atlsJ1yl5Z #mdpibiomedicines via @Biomed_MDPI
#endothelial #inflammation